11 Recruiting Studies Using Empagliflozin 25 Mg
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Empagliflozin 25 Mg
Empagliflozin in ESKD - A Feasibility Study
📍 University of Mississippi Medical Center — Jackson, Mississippi
Kidney Failure, Chronic
View Study & Checklist ➔SGLTi, Hepatic Glucose Production and Ketogenesis
📍 Texas Diabetes Institute/UH — San Antonio, Texas
Type 2 Diabetes
View Study & Checklist ➔SGLT2i, Pioglitazone, and Ketone Production in T2D
📍 Texas Diabetes Institute/UH — San Antonio, Texas
Type 2 Diabetes
View Study & Checklist ➔meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
📍 Toronto General Hospital — Toronto, Ontario
Peritoneal Dialysis Complication
View Study & Checklist ➔The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
📍 Vanderbilt University Medical Center — Nashville, Tennessee
Obesity
View Study & Checklist ➔Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease
📍 Yale University — New Haven, Connecticut
End Stage Renal Disease on Dialysis
View Study & Checklist ➔SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia
📍 Texas Diabetes Institute/UH — San Antonio, Texas
Type 2 Diabetes
View Study & Checklist ➔SGLT2i, Hepatic Glucose Production, and SNS
📍 Texas Diabetes Institute/UH — San Antonio, Texas
Type 2 Diabetes
View Study & Checklist ➔Ketones, SGLT2, HFrEF
📍 Texas Diabetes Institute - University Health System — San Antonio, Texas
Type2diabetes
View Study & Checklist ➔SGLT2i Therapy in Islet Transplantation (SIT)
📍 University of Minnesota — Minneapolis, Minnesota
Partial Islet Function
View Study & Checklist ➔SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan
📍 University of Texas Health Science Center at San Antonio — San Antonio, Texas
Type2 Diabetes
View Study & Checklist ➔